Endometrial Committee General Assembly report - David Miller
8000 0830 kian aan gap overview
1 LMS Study (GOG 0277) A Phase III randomised trial of gemcitabine plus docetaxel followed by doxorubicin versus observation for uterus limited, high grade.
EORTC 1208 MINITUB: Prospective Registry on Sentinel Node (SN) Positive Melanoma patients with minimal SN Tumor Burden who undergo Completion Lymph Node.
Study proposal After 4 A Phase III intergroup trial on adjuvant therapy in radically operated endometrial cancer patients (FIGO stage IC-IIIC) with high.
New Evidence reports on presentations given at ASH 2010 Rituximab in the Treatment of NHL: Rituximab versus Watch and Wait in Asymptomatic FL, R-Maintenance.
Study coordinator: Alexander van Akkooi (Rotterdam, NL)
Endometrial Committee
LMS Study (GOG 0277)
Endometrial Committee David Scott Miller, M.D., F.A.C.O.G., F.A.C.S. Director and Dallas Foundation Chair in Gynecologic Oncology Professor of Obstetrics.
